K Oeser1, J Maxeiner2, C Symowski1, M Stassen2, D Voehringer1. 1. Department of Infection Biology, University Hospital Erlangen at the Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany. 2. Asthma Core Facility, The Research Center Immunotherapy (FZI) at the University Hospital Mainz, Mainz, Germany.
Abstract
BACKGROUND: IL-4 and IL-13 play a crucial role during allergic asthma. Both cytokines can be produced by T cells and a variety of cell types of the innate immune system. The relative contribution of T-cell-derived vs innate IL-4/IL-13 for allergic inflammation and airway hyperreactivity remains unclear. METHODS: We compared the severity of OVA/alum-induced allergic lung inflammation in WT BALB/c mice to mice that lack expression of IL-4/IL-13 only in T cells (4-13Tko) or in all cell types (4-13ko). RESULTS: T-cell-derived IL-4/IL-13 was required for IgG1 and IgE production, recruitment of eosinophils and basophils to the lung, goblet cell hyperplasia, expression of Muc5ac, Clca3, and RELMβ, differentiation of alternatively activated macrophages, and airway hyperreactivity. Interestingly, ILC2 recruitment to the lung occurred independently of T-cell-derived IL-4/IL-13 but was diminished in the absence of IL-4/IL-13 from all cell types. Thus, the number of IL-4/IL-13-competent ILC2s did not correlate with the severity of lung pathology. CONCLUSIONS: Th2 cells appear to be the critical IL-4/IL-13-expressing cell type for the induction of allergic airway inflammation and airway hyperreactivity. The translational perspective of our results indicates that inhibition or reprogramming of Th2 cells may be very effective for the treatment of allergic asthma.
BACKGROUND:IL-4 and IL-13 play a crucial role during allergic asthma. Both cytokines can be produced by T cells and a variety of cell types of the innate immune system. The relative contribution of T-cell-derived vs innate IL-4/IL-13 for allergic inflammation and airway hyperreactivity remains unclear. METHODS: We compared the severity of OVA/alum-induced allergic lung inflammation in WT BALB/c mice to mice that lack expression of IL-4/IL-13 only in T cells (4-13Tko) or in all cell types (4-13ko). RESULTS: T-cell-derived IL-4/IL-13 was required for IgG1 and IgE production, recruitment of eosinophils and basophils to the lung, goblet cell hyperplasia, expression of Muc5ac, Clca3, and RELMβ, differentiation of alternatively activated macrophages, and airway hyperreactivity. Interestingly, ILC2 recruitment to the lung occurred independently of T-cell-derived IL-4/IL-13 but was diminished in the absence of IL-4/IL-13 from all cell types. Thus, the number of IL-4/IL-13-competent ILC2s did not correlate with the severity of lung pathology. CONCLUSIONS: Th2 cells appear to be the critical IL-4/IL-13-expressing cell type for the induction of allergic airway inflammation and airway hyperreactivity. The translational perspective of our results indicates that inhibition or reprogramming of Th2 cells may be very effective for the treatment of allergic asthma.
Authors: Marcus J Robinson; Melanie Prout; Helen Mearns; Ryan Kyle; Mali Camberis; Elizabeth E Forbes-Blom; William E Paul; Christopher D C Allen; Graham Le Gros Journal: J Immunol Date: 2017-01-23 Impact factor: 5.422
Authors: Sergei I Ochkur; Alfred D Doyle; Elizabeth A Jacobsen; William E LeSuer; Wen Li; Cheryl A Protheroe; Katie R Zellner; Dana Colbert; HuaHao H Shen; Charlie G Irvin; James J Lee; Nancy A Lee Journal: J Leukoc Biol Date: 2017-05-17 Impact factor: 4.962
Authors: A Cait; M R Hughes; F Antignano; J Cait; P A Dimitriu; K R Maas; L A Reynolds; L Hacker; J Mohr; B B Finlay; C Zaph; K M McNagny; W W Mohn Journal: Mucosal Immunol Date: 2017-10-25 Impact factor: 7.313
Authors: Sejal Saglani; Lisa G Gregory; Avneet K Manghera; William J Branchett; Faith Uwadiae; Lewis J Entwistle; R A Oliver; Jessica E Vasiliou; Rebekah Sherburn; Stephen Lui; F Puttur; David Vöhringer; Simone A Walker; James Buckley; Ruth Grychtol; Valentina Fainardi; Laura Denney; Adam Byrne; Erika von Mutius; Andrew Bush; Clare M Lloyd Journal: Sci Immunol Date: 2018-09-07